Volume 67, Issue 6, Pages (June 2005)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Associations Between Low Serum Testosterone and All-Cause Mortality and Infection- Related Hospitalization in Male Hemodialysis Patients: A Prospective.
Beta blockers in the management of chronic kidney disease
Iron indices: What do they really mean?
A. Besarab  Kidney International  Volume 69, Pages S13-S18 (May 2006)
Iron status and iron supplementation in peritoneal dialysis patients
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients  Demetrios J. Kutsogiannis, R.T.Noel.
Clinical impact of antibiotic-resistant Gram-positive pathogens
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
J.-P. Stahl  Clinical Microbiology and Infection 
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
C-reactive protein and dialysis access
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Volume 63, Issue 6, Pages (June 2003)
Volume 54, Issue 2, Pages (August 1998)
Kamyar Kalantar-Zadeh  Kidney International 
Bacterial resistance—the clinical challenge
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 61, Issue 3, Pages (March 2002)
Strategies for managing today's infections
Volume 68, Issue 6, Pages (December 2005)
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Journal of Renal Nutrition
Survival advantage in Asian American end-stage renal disease patients1
Joseph W. Eschbach, John W. Adamson  Kidney International 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
This Month in AJKD American Journal of Kidney Diseases
Y. Tveten, A. Jenkins, A.G. Allum, B.-E. Kristiansen 
Volume 155, Issue 1, Pages (January 2019)
Volume 70, Issue 12, Pages (December 2006)
Anemia as a risk factor for cardiovascular disease
P.M. Hawkey  Clinical Microbiology and Infection 
Blood pressure targets in hemodialysis patients
Evolving problems with resistant pathogens
Volume 59, Issue 2, Pages (February 2001)
Recent experience with high-dose intravenous iron administration
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.
Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.
Alternate-day dialysis may be needed for hemodialysis patients
E. Tacconelli  Clinical Microbiology and Infection 
Cardiovascular disease in pediatric chronic dialysis patients
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Volume 55, Issue 5, Pages (May 1999)
B.A. Cunha  Clinical Microbiology and Infection 
American Journal of Kidney Diseases
Daily nocturnal home hemodialysis
Racial differences in survival of patients on dialysis
Volume 72, Issue 3, Pages (August 2007)
Volume 61, Issue 2, Pages (February 2002)
G.C. Schito  Clinical Microbiology and Infection 
Stephen P. Mcdonald, Graeme R. Russ  Kidney International 
Volume 63, Issue 3, Pages (March 2003)
Charles A. Herzog  Kidney International 
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa 
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
Volume 64, Issue 4, Pages (October 2003)
Volume 82, Issue 9, Pages (November 2012)
Management of Gram-Positive Coccal Bacteremia and Hemodialysis
Volume 70, Issue 10, Pages (November 2006)
Volume 67, Issue 6, Pages (June 2005)
Volume 87, Issue 6, Pages (June 2015)
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Presentation transcript:

Volume 67, Issue 6, Pages 2508-2519 (June 2005) Bacterial infections in hemodialysis patients: Pathogenesis and prevention  Bertrand L. Jaber  Kidney International  Volume 67, Issue 6, Pages 2508-2519 (June 2005) DOI: 10.1111/j.1523-1755.2005.00364.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Annual death rates due to sepsis (A) and pulmonary infections (B) among dialysis patients (black line) compared with the general population (gray line). The data are stratified by age and are shown on a logarithmic (A) or normal (B) scale. Reproduced with permission from[2],[3]. Kidney International 2005 67, 2508-2519DOI: (10.1111/j.1523-1755.2005.00364.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Pathogenesis of bacteremia in hemodialysis patients. Gray boxes contain common pathogenic factors, white boxes therapeutic strategies. Kidney International 2005 67, 2508-2519DOI: (10.1111/j.1523-1755.2005.00364.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Kaplan-Meier survival curves for bacterial infections (bacteremia and pneumonia) stratified by iron storage indices prior to initiation of intravenous iron therapy. Functional iron deficiency is defined as ferritin = 100 to 800 ng/mL and transferrin saturation (TSAT) <20%; iron deficiency, ferritin <100 ng/mL and TSAT <20%; and iron replete state, ferritin = 100 to 800 ng/mL and TSAT >20%. Reproduced with permission from[23]. Kidney International 2005 67, 2508-2519DOI: (10.1111/j.1523-1755.2005.00364.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Dialysis facilities in the United States reporting colonization or infection with vancomycin-resistant enterococcus (VRE, gray line) or methicillin-resistant Staphylococcus aureus (MRSA, black line). The data are provided by the national surveillance of dialysis-associated diseases, 1995–2001, United States. Reproduced with permission from[70]. Kidney International 2005 67, 2508-2519DOI: (10.1111/j.1523-1755.2005.00364.x) Copyright © 2005 International Society of Nephrology Terms and Conditions